VIVITROL®

(naltrexone for extended-release injectable suspension)

Prescribing Information Medication Guide
Publications

Studies designed, executed, and funded by Alkermes Inc.

Apr 2005
Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial
JAMA
AUTHOR(S)

Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW, et al.

View on PubMed
Clinical
Alcohol Use Disorder
Sep 2007
Efficacy of Extended-Release Naltrexone in Alcohol-Dependent Patients Who Are Abstinent Before Treatment
The Journal of Clinical Pharmacology
AUTHOR(S)

O'Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR

View on PubMed
Clinical
Alcohol Use Disorder
Apr 2011
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
The Lancet
AUTHOR(S)

Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL

View on PubMed
Clinical
Opioid Use Disorder
Sep 2013
Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness
Addiction
AUTHOR(S)

Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, Silverman BL

View on PubMed
Clinical
Opioid Use Disorder